Nazarova Valeriya Vitalevna

Oncologist, PhD in Medical Sciences

Speciality

Nazarova Valeria Vitalievna is an oncologist, a specialist in diagnosing and treating skin cancer at “Melanoma Unit” Moscow. Valeria Vitalievna is one of the few doctors in Russia leading the scientific activity “Treatment of patients with metastatic uveal melanoma (melanoma of the eye)”. Dr Valeria Vitalievna is the developer of an electronic system with the help of which it became possible to diagnose oncological diseases remotely. The doctor has repeatedly presented the development at scientific conferences, such as the World Congress of Melanoma (Germany 2013), Global Controversies and Advances in Skin Cancer (Australia, Brisbane 2013), etc.

Early diagnosis of oncological pathologies of the skin and other neoplasms.
Digital dermatoscopy on the FotoFinderBodyStudioATBM device.
Immunotherapy and targeted therapy of metastatic and solid tumors.
Therapy of melanoma of the eye (uveal melanoma).

Education

2010 – Moscow State University of Medicine and Dentistry named after AI Evdokimov
2012 – Residency in the department of tumor biotherapy of the National Medical Research Center of Oncology named after N.N. Blokhin, qualification “oncologist”.
2018 – Had trained in Barcelona, the 9th World Congress of Melanoma and Skin Cancer, on the topic: The first line of therapy for metastatic uveal melanoma
2009 – Thesis “Treatment and prognosis of metastatic uveal melanoma”, Having the degree of PhD in Medical Sciences

Scientific works and publications

In 2007, Valeria Vitalievna was awarded a diploma for the best work on the topic “Glioma”
In 2009, Dr Nazarova participated in the “II EAFO Basic Oncology Course (Minsk)
Valeria Nazarova is a member of the American Society of Clinical Oncology (ASCO), the European Society of Medical Oncology (ESMO), and the Russian Society of Clinical Oncology (RUSSCO).
Dr Valeria Vitalievna is the developer of an electronic system with the help of which it became possible to diagnose oncological diseases remotely.
The doctor has repeatedly presented the development at scientific conferences, such as the World Congress of Melanoma (Germany 2013), Global Controversies and Advances in Skin Cancer (Australia, Brisbane 2013).